[Treatment of chronic coronary insufficiency with recordil]. 1974

L N Solomonova, and T I Sukasova, and R N Berezovskii

UI MeSH Term Description Entries
D008297 Male Males
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator
D050356 Lipid Metabolism Physiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS. Metabolism, Lipid

Related Publications

L N Solomonova, and T I Sukasova, and R N Berezovskii
October 1979, Kardiologiia,
L N Solomonova, and T I Sukasova, and R N Berezovskii
July 1972, Kardiologiia,
L N Solomonova, and T I Sukasova, and R N Berezovskii
January 1972, Marseille medical,
L N Solomonova, and T I Sukasova, and R N Berezovskii
November 1968, Kardiologiia,
L N Solomonova, and T I Sukasova, and R N Berezovskii
January 1989, AMB : revista da Associacao Medica Brasileira,
L N Solomonova, and T I Sukasova, and R N Berezovskii
January 1973, Polskie Archiwum Medycyny Wewnetrznej,
L N Solomonova, and T I Sukasova, and R N Berezovskii
January 1974, Grudnaia khirurgiia (Moscow, Russia),
L N Solomonova, and T I Sukasova, and R N Berezovskii
October 1961, Zdravookhranenie Belorussii,
L N Solomonova, and T I Sukasova, and R N Berezovskii
March 1999, Annales de cardiologie et d'angeiologie,
L N Solomonova, and T I Sukasova, and R N Berezovskii
October 1969, Kardiologiia,
Copied contents to your clipboard!